Cryo Cell International Inc Revenue Growth Rates (CCEL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Cryo cell International Inc   (NYSEAMER: CCEL)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

CCEL's Revenue Growth by Quarter and Year

Cryo Cell International Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CCEL Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter November -
3rd Quarter August -
2nd Quarter May 7.78
1st Quarter February 7.68
FY 15.46

CCELs Annual Revenue
Cryo Cell International Inc 's Revenue in the fiscal year 2025 $ 31.57 millions
Cryo Cell International Inc 's Revenue in the fiscal year 2024 $ 31.99 millions
Cryo Cell International Inc 's Revenue in the fiscal year 2023 $ 31.34 millions
Cryo Cell International Inc 's Revenue in the fiscal year 2022 $ 30.34 millions
Cryo Cell International Inc 's Revenue in the fiscal year 2021 $ 28.88 millions




CCEL Revenue second quarter 2026 Y/Y Growth Comment
Cryo Cell International Inc reported decrease in Revenue in the second quarter 2026 by -1.94% to $ 7.78 millions, from the same quarter in 2025.
The decrease in the second quarter 2026 Cryo Cell International Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 4.08%.

Looking into second quarter 2026 results within Healthcare Facilities industry 31 other companies have achieved higher Revenue growth. While Cryo Cell International Inc ' s Revenue decline of -1.94% ranks overall at the positon no. 2951 in the second quarter 2026.


CCEL Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter November - -2.24 % 1.78 % 1.55 %
3rd Quarter August - -2.97 % 2.54 % 2.47 %
2nd Quarter May -1.94 % -1.37 % 3.47 % 1.83 %
1st Quarter February -3.64 % 1.53 % 0.38 % 7.71 %
FY   - -1.28 % 2.04 % -

Financial Statements
Cryo Cell International Inc 's second quarter 2026 Revenue $ 7.78 millions CCEL's Income Statement
Cryo Cell International Inc 's second quarter 2025 Revenue $ 7.93 millions Quarterly CCEL's Income Statement


CCEL Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter November - 0.13 % -0.62 % 0.13 %
3rd Quarter August - -1.26 % 0.37 % 1.29 %
2nd Quarter May 1.25 % -0.5 % 2.42 % -0.64 %
1st Quarter February -2.04 % -0.62 % -0.38 % 0.77 %
FY (Year on Year)   - -1.28 % 2.04 % -


Back to CCEL Growth rate Comparisons >> Back to CCEL Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #32
Healthcare Sector #412
Overall #2951

Revenue Y/Y Growth Statistics
High Average Low
32.72 % 4.08 % -9.97 %
 
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #32
Healthcare Sector #412
Overall #2951
Revenue Y/Y Growth Statistics
High Average Low
32.72 % 4.08 % -9.97 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Cryo Cell International Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
20.62 % 1.09 % -12.78 %
(Aug 31 2018)  


CCEL's II. Quarter Q/Q Revenue Comment
Cryo cell International Inc achieved in the II. Quarter 2026 above company average sequential Revenue growth of 1.25%, to $ 7.78 millions, from $7.68 millions in the first quarter.
CCEL is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Healthcare Facilities industry 17 other companies have achieved higher Revenue quarter on quarter growth. While Cryo Cell International Inc 's Revenue growth quarter on quarter, overall rank is 1590.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #18
Healthcare Sector #216
Overall #1590
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #18
Healthcare Sector #216
Overall #1590
Revenue Q/Q Growth Statistics
High Average Low
20.62 % 1.09 % -12.78 %
(Aug 31 2018)  


CCEL's II. Quarter Q/Q Revenue Comment
Cryo cell International Inc achieved in the II. Quarter 2026 above company average sequential Revenue growth of 1.25%, to $ 7.78 millions, from $7.68 millions in the first quarter.
CCEL is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Healthcare Facilities industry 17 other companies have achieved higher Revenue quarter on quarter growth. While Cryo Cell International Inc 's Revenue growth quarter on quarter, overall rank is 1590.


Cryo Cell International Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(May 31 2026)		 12 Months Ending
(Feb 28 2026)		 12 Months Ending
(Nov 30 2025)		 12 Months Ending
(Aug 31 2025)		 12 Months Ending
(May 31 2025)
Cumulative Revenue 12 Months Ending $ 31.13 $ 31.28 $ 31.57 $ 31.75 $ 31.99
Y / Y Revenue Growth (TTM) -2.69 % -2.56 % -1.31 % -0.29 % 1.1 %
Year on Year Revenue Growth Overall Ranking # 2887 # 3150 # 2538 # 2358 # 2116
Seqeuential Revenue Change (TTM) -0.49 % -0.91 % -0.57 % -0.75 % -0.36 %
Seq. Revenue Growth (TTM) Overall Ranking # 2887 # 3150 # 2538 # 2358 # 2116


Cumulative Revenue growth Comment
Cryo Cell International Inc 's cumulative 12 months Revenue continue to decrease, but on the faster rate at -2.69% year on year, at May 31 2026 compare to the -2.56% decrease at Feb 28 2026. If the Cryo Cell International Inc 's fiscal year would end at May 31 2026, annual Revenue would be $31 millions.

In the Healthcare sector 365 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2887, from total ranking in previous quarter at 3150.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 27
Healthcare Sector # 366
Overall # 2537

Revenue TTM Y/Y Growth Statistics
High Average Low
22.83 %
 4.36 %
-7.81 %
(May 31 2019)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 380
S&P 500 # 2666
Cumulative Revenue growth Comment
Cryo Cell International Inc 's cumulative 12 months Revenue continue to decrease, but on the faster rate at -2.69% year on year, at May 31 2026 compare to the -2.56% decrease at Feb 28 2026. If the Cryo Cell International Inc 's fiscal year would end at May 31 2026, annual Revenue would be $31 millions.

In the Healthcare sector 365 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2887, from total ranking in previous quarter at 3150.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 27
Healthcare Sector # 366
Overall # 2537

Revenue TTM Y/Y Growth Statistics
High Average Low
22.83 %
4.36 %
-7.81 %
(May 31 2019)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 380
S&P 500 # 2666




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CCEL's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending May 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending May 31 2026
Neogen Corporation-0.58%$ -0.581 millions
Cryo cell International Inc -1.93%$ -1.926 millions
Nurix Therapeutics Inc -79.47%$ -79.474 millions


About Cryo Cell International Inc Revenue Growth Rates (CCEL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Cryo Cell International Inc (CIK 862692).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-304834
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Cryo Cell International Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.